CEP350 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.121800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.213200E-01
Normal-vs-Stage2
4.116200E-01
Normal-vs-Stage3
1.952650E-01
Normal-vs-Stage4
6.863400E-01
Stage1-vs-Stage2
4.716800E-01
Stage1-vs-Stage3
2.644500E-02
Stage1-vs-Stage4
4.468600E-01
Stage2-vs-Stage3
1.622760E-04
Stage2-vs-Stage4
3.884600E-01
Stage3-vs-Stage4
1.503410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.763400E-01
Normal-vs-AfricanAmerican
7.810000E-01
Normal-vs-Asian
4.889200E-01
Caucasian-vs-AfricanAmerican
8.665700E-02
Caucasian-vs-Asian
9.602200E-01
AfricanAmerican-vs-Asian
1.722020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.789000E-01
Normal-vs-Female
4.739000E-01
Male-vs-Female
7.564400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.252400E-01
Normal-vs-Age(41-60Yrs)
7.547800E-01
Normal-vs-Age(61-80Yrs)
3.096600E-01
Normal-vs-Age(81-100Yrs)
1.898820E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.551800E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.825200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.519600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.233600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.150200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.040800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.114600E-01
Normal-vs-Daily Drinker
6.767600E-02
Normal-vs-Weekly Drinker
4.292800E-01
Normal-vs-Occasional Drinker
5.182200E-01
Normal-vs-Social Drinker
6.541600E-01
Non Drinker-vs-Daily Drinker
2.009200E-01
Non Drinker-vs-Weekly Drinker
7.183400E-01
Non Drinker-vs-Occasional Drinker
2.785400E-01
Non Drinker-vs-Social Drinker
2.271600E-01
Daily Drinker-vs-Weekly Drinker
1.947250E-01
Daily Drinker-vs-Occasional Drinker
3.449700E-02
Daily Drinker-vs-Social Drinker
3.664400E-02
Weekly Drinker-vs-Occasional Drinker
6.178400E-01
Weekly Drinker-vs-Social Drinker
5.333000E-01
Occasional Drinker-vs-Social Drinker
8.299400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.032200E-02
Normal-vs-Grade 2
8.843900E-03
Normal-vs-Grade 3
2.399900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.595200E-01
Grade 1-vs-Grade 3
3.241800E-01
Grade 1-vs-Grade 4
5.032200E-02
Grade 2-vs-Grade 3
5.522200E-01
Grade 2-vs-Grade 4
8.843900E-03
Grade 3-vs-Grade 4
2.399900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.009000E-01
Normal-vs-NonDiabetic
2.671000E-01
Diabetic-vs-NonDiabetic
3.312400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.369440E-01
Normal-vs-NoPancreatitis
2.903800E-01
Pancreatitis-vs-NoPancreatitis
4.284400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.400200E-01
Normal-vs-N1
3.868800E-01
N0-vs-N1
7.014800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.930600E-01
Normal-vs-TP53-NonMutant
7.332600E-01
TP53-Mutant-vs-TP53-NonMutant
8.674400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
